Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and neurokinin a

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with neurokinin a in 8 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (neurokinin a)	Trials (neurokinin a)	Recent Studies (post-2010) (neurokinin a)
9,156	187	552	1,765	34	91

Protein Interaction Comparison

Protein	Taxonomy	1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)	neurokinin a (IC50)
Substance-K receptor	Homo sapiens (human)		0.0017
Neuromedin-K receptor	Homo sapiens (human)		0.045
Substance-K receptor	Mesocricetus auratus (golden hamster)		0.001

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (12.50)	18.7374
1990's	7 (87.50)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brunelleschi, S; Fantozzi, R; Giotti, A; Tarli, S	1
Drazen, JM; Martins, MA; Shore, SA	1
Gerard, NP	1
Woodhead, CJ	1
Barnes, PJ; Hirayama, Y; Lei, YH; Rogers, DF	1
Bertrand, C; Desai, MC; Geppetti, P; Nadel, JA; Piedimonte, G; Snider, RM	1
Hess, HJ; Kanai, Y; Lowe, JA; Nagahisa, A; Suga, O; Taniguchi, K; Tsuchiya, M	1
Akuta, K; Manabe, H; Ohmori, K; Okamura, K	1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and neurokinin a

Article	Year
Neuropeptides in nasal mucosa. Clinical otolaryngology and allied sciences, 1994, Volume: 19, Issue:4 Topics: Bradykinin; Calcitonin Gene-Related Peptide; Cytokines; Eicosanoids; Histamine H1 Antagonists; Humans; Nasal Mucosa; Nasal Polyps; Neurokinin A; Neuropeptide Y; Platelet Activating Factor; Receptors, Calcitonin Gene-Related Peptide; Rhinitis; Substance P; Vasoactive Intestinal Peptide	1994

Other Studies

7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and neurokinin a

Article	Year
Priming effects of mammalian tachykinins on human neutrophils. Life sciences, 1991, Volume: 48, Issue:2 Topics: Dose-Response Relationship, Drug; Humans; Neurokinin A; Neurokinin B; Neutrophils; Platelet Activating Factor; Stimulation, Chemical; Substance P; Superoxides; Tachykinins	1991
Release of tachykinins by histamine, methacholine, PAF, LTD4, and substance P from guinea pig lungs. The American journal of physiology, 1991, Volume: 261, Issue:6 Pt 1 Topics: Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Guinea Pigs; Histamine; Kinetics; Lung; Male; Methacholine Chloride; Neprilysin; Neurokinin A; Platelet Activating Factor; SRS-A; Substance P; Tachykinins	1991
Characterization of substance P contractile activity on isolated guinea pig lung tissues. The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:3 Topics: Animals; Dose-Response Relationship, Drug; Glycopeptides; Guinea Pigs; In Vitro Techniques; Indomethacin; Lung; Male; Muscle Contraction; Neurokinin A; Neuropeptides; Platelet Activating Factor; Prostaglandins; Receptors, Neurokinin-1; Receptors, Neurotransmitter; Substance P; Trachea	1987
Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo. British journal of pharmacology, 1993, Volume: 108, Issue:3 Topics: Animals; Blood Pressure; Bronchoconstriction; Capsaicin; Dipeptides; Electric Stimulation; Evans Blue; Exudates and Transudates; Guinea Pigs; Hypotension; Indoles; Male; Neurokinin A; Peptide Fragments; Peptides, Cyclic; Platelet Activating Factor; Receptors, Neurokinin-2; Receptors, Neurotransmitter; Respiratory Mechanics; Smoking; Substance P; Vagus Nerve	1993
A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:1 Topics: Animals; Capillary Permeability; Capsaicin; Dose-Response Relationship, Drug; Edema; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Hypertonic Solutions; Neurokinin A; Neurons, Afferent; Piperidines; Platelet Activating Factor; Rats; Rats, Inbred F344; Receptors, Neurotransmitter; Receptors, Tachykinin; Sodium Chloride; Stimulation, Chemical; Substance P; Trachea; Tracheal Diseases	1993
Antiinflammatory and analgesic activity of CP-96,345: an orally active non-peptide substance P receptor antagonist. Regulatory peptides, 1993, Jul-02, Volume: 46, Issue:1-2 Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Bradykinin; Dose-Response Relationship, Drug; Evans Blue; Guinea Pigs; Histamine; Leukotriene D4; Male; Neurokinin A; Neurokinin B; Neurokinin-1 Receptor Antagonists; Platelet Activating Factor; Receptors, Neurokinin-1; Skin; Substance P; Ureter	1993
KF19514, a phosphodieterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pigs. International archives of allergy and immunology, 1997, Volume: 114, Issue:4 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Acetylcholine; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Electric Stimulation; Eosinophils; Guinea Pigs; Muscle Contraction; Muscle, Smooth; Naphthyridines; Neurokinin A; Neutrophils; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Activating Factor; Pyrrolidinones; Respiratory Therapy; Rolipram; Substance P	1997